Latest filing published 17 Sept 2026 for AstraZeneca PLC, €8.5M.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Pascal Soriot: trading record in brief
Pascal Soriot (chief executive) discloses dealings in AstraZeneca PLC to Finansinspektionen. Over a trading history stretching from 11 February 2021 to 14 September 2026, the count stands at 30 filings.
No open-market sale appears; the market trades are 6 purchases worth €10.9M. The amount is not disclosed for 4 filings. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 19 share grants. 2026 to date brings 4 purchases and no sales.
The latest filing, published on 17 September 2026, reports an open-market purchase of €8.5M in AstraZeneca PLC. The median gap between a trade and its publication by Finansinspektionen is 3 days. Under the Market Abuse Regulation, managers have three business days to notify their trades. These figures are compiled from regulatory filings published by Finansinspektionen. They describe what insiders did and are not a recommendation.
Companies and markets linked to Pascal Soriot
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 60,000 shares@ £121.020.0033% mcap4.8% of flowAktieISIN GB0009895292FI:csv-d0f36b329167e863286fCanonical exit: 13 Dec 2026 (T+90)
- 18,359 shares0AktieISIN GB0009895292FI:csv-fdb5b74349479ecd7306Canonical exit: 12 Aug 2026 (T+90)
- 101,495 shares0AktieISIN GB0009895292FI:csv-5c2fb9abdd6148ef6f4dCanonical exit: 3 Jun 2026 (T+90)
- 14,967 shares0AktieISIN GB0009895292FI:csv-0b32b4e129778e2ddd2aCanonical exit: 2 Jun 2026 (T+90)
- 103,581 shares@ £152.4210.2% of flowAktieISIN GB0009895292FI:csv-8037ffad926a45424c84
- 136,537 shares0AktieISIN GB0009895292FI:A003T466-1
- 297,418 shares0AktieISIN GB0009895292FI:A003Q108-1
- 29,474 shares@ £100.8116.6% of flowAktieISIN GB0009895292FI:A003Q107-1
- 124,404 shares@ £119.6310.1% of flowAktieISIN GB0009895292FI:A003Q109-1
- 248 shares0AktieISIN GB0009895292FI:A003Q111-1
- 17,357 shares0AktieISIN GB0009895292FI:A003Q110-1
- 89,962 shares0AktieISIN GB0009895292FI:A003Q112-1
- 8,970 shares0AktieISIN GB0009895292FI:A003O753-1
- 20,000 shares@ £102.031.4% of flowAktieISIN GB0009895292FI:csv-c6391b0103738e5791a2Canonical exit: 12 Feb 2025 (T+90)
- 105,238 shares0AktieISIN GB0009895292FI:csv-6e27decc1fee0afb590e
- 109,872 shares@ £100.817.3% of flowAktieISIN GB0009895292FI:csv-02f437e3ddb62ceeb587
- 17,702 shares0AktieISIN GB0009895292FI:csv-c8fc138a6a1fd89ed575
- 12,345 shares0AktieISIN GB0009895292FI:csv-d80331708ee919be2e9c
- 138,093 shares0AktieISIN GB0009895292FI:csv-6a6cc5c790aa19562c3e
- 100,256 shares@ £108.216.9% of flowAktieISIN GB0009895292FI:csv-6c49404c7b3389267cc6
- 8,853 shares0AktieISIN GB0009895292FI:csv-8012956b693161d6a648
- 15,187 shares0AktieISIN GB0009895292FI:csv-40c60d3d7659579bf515
- 163,838 shares0AktieISIN GB0009895292FI:csv-4aa323a0891d5c7c2e86
- 129,784 shares0AktieISIN GB0009895292FI:csv-25855351bdbec8ac9f6e
- 9,930 shares0AktieISIN GB0009895292FI:csv-104a76f959f2bd03d8b6
25 of 30 declarations
